CALL US NOW :
+91 124 423 0204
@@ Please be patient!! Your registration is in progress.
Indian Diagnostic and pathology Laboratory market is one of the fastest growing market in the country. Several factors such as rise in health care spending, awareness of health related concerns, high prevalence of diseases, increase incidences of lifestyle diseases and penetration of health care insurance are acting as drivers for the market.
In present scenario, market players operate in this market through three business models including single laboratory model, multiple laboratory model and partnered laboratory model. In addition to this, the government owned laboratories are also operating in the market. Consequently, the market could be recorded as fragmented in nature with large number of players in the market. However, intensified competition is observed among major four players-SRL, Thyrocare, Dr. Lal Path, and Metropolis.
On the basis of the tests performed by these laboratories, the overall India diagnostic and pathology laboratory market has been segmented into radiology and pathology tests by test type. These test types are further segmented on the basis of type of test and source for tests. By source of test, pathology tests have been segmented into blood, urine, stool, and body tissue.
The upcoming report is currently available for pre-order and will be published in the month of January 2017. For more information on the coverage, approach and timeline, send us your query at firstname.lastname@example.org
Tentative Scope-India Diagnostic and Pathology Laboratory Market
2.1. Market Definitions
2.3. Market Size and Modeling
3.1. By Revenue, FY’2011-FY’2016
3.2. By Number of Tests and Number of Labs, FY’2011-FY’2016
4.1. By Pathology and Radiology Tests, FY’2011 - FY’2016
4.2. By Hospital-based Diagnostic Laboratories, Polyclinics and Independent Diagnostic Laboratories
4.3. By Region/ Zones (South, North, West, East, and Central)
4.4. By Tier I, Tier II, and Tier III Cities (Cover top 5 cities)
4.5. By Organized and Unorganized Players
4.6. By Government and Privately Owned Diagnostic and Pathology Laboratories
5.1. Market Size by Revenue, FY’ 2016
5.2. Market Segmentation
5.2.1. By Type of Pathology (Clinical Pathology,Clinical microbiology,Hematology and Homeostasis,Molecular Diagnostics, Surgical Pathology)
5.2.2. By Source of Test (Blood, Urine, Stool, and Body Tissue)
5.3. Market Share of Major Players in Pathology Test (by Revenue or by number of test), FY’2016
6.1. Market Size by Revenue, FY’ 2016
6.2. Market Segmentation
6.2.1. By Type of Test (X-Ray, Ultrasound, ECG, EEG, MRI, Mammography, and Others)
6.3. Market Share of Major Players in Radiology Test (by Revenue or by number of test), FY’2016
15.1.India Diagnostic and Pathology Laboratory Market by Revenue , FY’ 2017-FY’2021
15.2.Future Analysis by Segmentation
15.3.Cause and Effect Relationship
15.4.Analyst Recommendations – Prerequisites to market entry
16.1.Prevalence of diseases, FY’2011 –FY’2020
16.2.Average Diagnostic spending in India , FY’2011 –FY’2020
16.3.Number of radiologists and Clinicians in India, FY’2011 –FY’2020
16.4.Expenditure of Government on Diagnostics Infrastructure in India, FY’2011 –FY’2020
Make a start to an incredible career
© Copyright 2017, KEN RESEARCH PVT. LTD. All rights reserved.